Search Results - "Buzon, Maria J"
-
1
Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations
Published in PLoS pathogens (01-08-2019)“…Latency reversal agents (LRAs) have proven to induce HIV-1 transcription in vivo but are ineffective at decreasing the size of the latent reservoir in…”
Get full text
Journal Article -
2
Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells
Published in PLoS pathogens (13-01-2022)“…The development of physiological models that reproduce SARS-CoV-2 infection in primary human cells will be instrumental to identify host-pathogen interactions…”
Get full text
Journal Article -
3
Resident memory T cells are a cellular reservoir for HIV in the cervical mucosa
Published in Nature communications (18-10-2019)“…HIV viral reservoirs are established very early during infection. Resident memory T cells (T RM ) are present in tissues such as the lower female genital…”
Get full text
Journal Article -
4
A Novel Single-Cell FISH-Flow Assay Identifies Effector Memory CD4 + T cells as a Major Niche for HIV-1 Transcription in HIV-Infected Patients
Published in mBio (11-07-2017)“…Cells that actively transcribe HIV-1 have been defined as the "active viral reservoir" in HIV-infected individuals. However, important technical limitations…”
Get full text
Journal Article -
5
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
Published in PLoS pathogens (01-04-2016)“…Resting CD4+ T-cells harboring inducible HIV proviruses are a critical reservoir in antiretroviral therapy (ART)-treated subjects. These cells express little…”
Get full text
Journal Article -
6
Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
Published in Journal of enzyme inhibition and medicinal chemistry (01-12-2022)“…Zinc pyrithione (1a), together with its analogues 1b-h and ruthenium pyrithione complex 2a, were synthesised and evaluated for the stability in biologically…”
Get full text
Journal Article -
7
Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab
Published in Nature communications (16-08-2019)“…The identification of exclusive markers to target HIV-reservoir cells will represent a significant advance in the search for therapies to cure HIV. Here, we…”
Get full text
Journal Article -
8
Identification of HIV-reservoir cells with reduced susceptibility to antibody-dependent immune response
Published in eLife (26-05-2022)“…HIV establishes a persistent infection in heterogeneous cell reservoirs, which can be maintained by different mechanisms including cellular proliferation, and…”
Get full text
Journal Article -
9
A Cell-Intrinsic Inhibitor of HIV-1 Reverse Transcription in CD4+ T Cells from Elite Controllers
Published in Cell host & microbe (11-06-2014)“…HIV-1 reverse transcription represents the predominant target for pharmacological inhibition of viral replication, but cell-intrinsic mechanisms that can block…”
Get full text
Journal Article -
10
Inhibition of HIV-1 Integration in Ex Vivo-Infected CD4 T Cells from Elite Controllers
Published in Journal of Virology (01-09-2011)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
11
Transcriptional Profiling of CD4 T Cells Identifies Distinct Subgroups of HIV-1 Elite Controllers
Published in Journal of Virology (01-03-2011)“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text
Journal Article -
12
Schlafen 12 restricts HIV-1 latency reversal by a codon-usage dependent post-transcriptional block in CD4+ T cells
Published in Communications biology (10-05-2023)“…Latency is a major barrier towards virus elimination in HIV-1-infected individuals. Yet, the mechanisms that contribute to the maintenance of HIV-1 latency are…”
Get full text
Journal Article -
13
The active human immunodeficiency virus reservoir during antiretroviral therapy: emerging players in viral persistence
Published in Current opinion in HIV & AIDS (01-07-2021)“…To discuss the role of CD4+ T cells with active Human immunodeficiency virus (HIV), meaning infected cells with transcriptional and/or translational viral…”
Get full text
Journal Article -
14
HIV-1 persistence in CD4+ T cells with stem cell–like properties
Published in Nature medicine (01-02-2014)“…Understanding how and where HIV-1 infection persists in the body is crucial for efforts to eradicate the viral reservoir. Now Mathias Lichterfeld and his…”
Get full text
Journal Article -
15
Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells
Published in Journal of virology (01-09-2014)“…Initiation of antiretroviral therapy during the earliest stages of HIV-1 infection may limit the seeding of a long-lasting viral reservoir, but long-term…”
Get full text
Journal Article -
16
HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects
Published in Nature medicine (01-04-2010)“…Despite highly active antiretroviral therapy, active replication persists and drives immune activation in some individuals with HIV. This activation is higher…”
Get full text
Journal Article -
17
Recommendations for measuring HIV reservoir size in cure-directed clinical trials
Published in Nature medicine (01-09-2020)“…Therapeutic strategies are being clinically tested either to eradicate latent HIV reservoirs or to achieve virologic control in the absence of antiretroviral…”
Get full text
Journal Article -
18
Increased coronary atherosclerosis and immune activation in HIV-1 elite controllers
Published in AIDS (London) (28-11-2012)“…HIV-1 elite controllers spontaneously maintain suppressed levels of viremia, but exhibit significant immune activation. We investigated coronary…”
Get full text
Journal Article -
19
Hepatitis C Therapy With Interferon-α and Ribavirin Reduces CD4 T-Cell–Associated HIV-1 DNA in HIV-1/Hepatitis C Virus–Coinfected Patients
Published in The Journal of infectious diseases (01-05-2014)“…Combined treatment with interferon alpha (IFN-α) and ribavirin (RBV) can effectively cure HCV infection in a significant proportion of patients, but effects of…”
Get full text
Journal Article -
20
Antibody cooperative adsorption onto AuNPs and its exploitation to force natural killer cells to kill HIV-infected T cells
Published in Nano today (01-02-2021)“…•We generate a new nanotool consisting of bispecific nanoparticles with cooperatively-adsorbed antibodies at their surface.•No modification of antibodies or…”
Get full text
Journal Article